National Institute of Virology (NIV) Current Affairs, GK & News

WHO: UK Variant of COVID-19 in 41 countries

The World Health Organisation recently announced that the United Kingdom covid-19 variant has been detected in more than 41 countries. The VOC-202012/01 the was first detected in South Africa. This variant is 70% more transmissible than the other covid-19 mutants. Has VOC-202012/01 reached India? Yes. Around 38 people have been found infected with the mutant. It has ..

Month: 

Category: 

Topics: 

COVID-19: ICMR develops “Purified Antisera” as treatment

The Indian Council of Medical Research along with Hyderabad based Biological E has developed “Purified Antisera”. The antiserum has been obtained from animals. This is to be used as a prophylaxis and treatment for COVID-19. Highlights The new therapy works just like that of plasma therapy. But here the plasma is obtained from animals. Antiserum ..

Month: 

Category: 

Topics: 

Dr. Dangs Lab to Partner with Bharat Biotech for Human Trials of Covaxin

The Delhi-based private laboratory, Dr Dangs Lab, has announced that they have been selected as the central laboratory for human clinical trials of Covaxin, which is touted as the first-ever indigenous vaccine developed by Bharat Biotech in collaboration with the Indian Council of Medical Research and National Institute of Virology, Pune. The human clinical trial ..

Month: 

Category: 

Topics: 

ICMR to launch COVAXIN on August 15

On July 2, 2020, Indian Council of Medical Research announced that it is to launch COVAXIN, India’s first COVID-19 vaccine by August 15. Highlights There are 12 institutes that are conducting the clinical trials of the indigenous vaccine. Currently India has two indigenous manufacturers that are approved to conduct clinical trials for COVID-19 vaccine. They ..

Month: 

Category: 

Topics: 

India approves second Vaccine Trial

The Drug Controller General of India approved to begin vaccine trial of Zydus Cadila. The firm is to conduct the vaccine trials in two phases. This is the second vaccine trial approved by India after Bharat Biotech’s COVAXIN. Highlights The DCGI approved the vaccine trials after the animal trials of the vaccine was satisfactory. The ..

Month: 

Category: 

Topics: